ArticleFrontiers in oncology2021

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14).

Marco Maruzzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.